| [1] Meng Jing-fang (孟静芳). Synthesis of lamivudine and emtricitabine(拉米夫定和恩曲他滨的合成)[D]. Shanghai(上海): Shanghai Institute of Pharmaceutical Industry(上海医药工业研究院), 2005.[2] Ma Zhi-long(马志龙), Zhang Qing-wen(张庆文). Graphical synthetic routes of emtricitabine(恩曲他滨合成路线图解)[J]. Chinese J Pharm(中国医药工业杂志), 2010, 41(8): 628-631.[3] Zhang Jian(张健). Synthesis of the new anti-HIV/HBV agent ET and anticancer agent CAP(抗HIV/HBV新药ET及抗肿瘤新药CAP的合成研究)[D]. Shanghai(上海): East China Normal University(华东师范大学)， 2005.[4] Jeong L S, Schinazi R F, Warren B J, et al. Asymmetric synthesis and biological evaluation of β-L-(2R, 5S) and α-(2R, 5R)-1, 3-oxathiolane-pyrimidine and purine nucleosides as potential anti-HIV agents[J]. J Med Chem, 1993, 36(2): 181-195.[5] Gong Ping(宫平), Wang Li-xin(王立心), Wu Xiu-jing(吴秀静), et al. Synthesis of 2(R)-hydroxymethyl-5(S)-(5′-fluorocytosin-1′-yl)-1, 3-oxathiolane(2)-羟甲基-(5S)-(5′-氟胞嘧啶-1′-基)-1, 3-氧硫杂环戊烷的合成)[J]. Chinese J Med Chem(中国药物化学杂志), 2002, 12(1): 34-36.[6] Ye Xiao-xia(叶晓霞), Le Jian(乐健), Yang Yong-jian(杨永健). Chiral Separation of emtricitabine enantiomers by HPLC(恩曲他滨对映体的HPLC法测定)[J]. Chinese J Pharm(中国医药工业杂志), 2011, 42(6): 447-448.[7] Fang Gui-zhen(房桂珍), An Qing-jun(安庆军), Huo Ming-shan(霍明山), et al. HPLC determination of related substance in emtricitabine(HPLC法测定恩曲他滨中有关物质)[J]. Chinese J Pharm Anal(药物分析杂志), 2011, 31(12): 2 325-2 329.[8] Yang Qiu-qing(杨秋青), Liu Bo-qian(刘博谦), Han Kang(韩康). Pure and mixed enantiomer of moxifloxacin hydrochloride studied by NMR spectroscopy(盐酸莫西沙星对映体及混合体的核磁共振研究)[J]. Chinese J Magn Reson(波谱学杂志), 2012, 29(1): 119-127.[9] Li Yan(李燕), Li Lin-sheng(李临生), Lan Yun-jun(兰云军). Calculation of 19F NMR chemical shifts of fluoroaromatics(氟苯类化合物19F NMR化学位移的计算)[J]. Chinese J Magn Reson(波谱学杂志), 2012, 29(2): 258-277.[10] Chen Mu-zi(陈木子), Wang Lu(王璐), Zhang Hai-lu (张海禄), et al. NMR analysis of targeted drug gefitinib(靶向新药吉非替尼的核磁共振波谱研究)[J]. Chinese J Magn Reson(波谱学杂志), 2011, 28(3): 413-418.[11] Ren Zhi-yao(任志尧). Synthesis of Emtricitabine(恩曲他滨合成研究)[D]. Guizhou(贵州)：Guizhou University(贵州大学)，2008. |
